A high-level delegation from the Government Experience Exchange Office of the United Arab Emirates embarked on a comprehensive visit to the Sheikh Zayed Institute for Paediatric Surgical Innovation in Washington. The delegation’s mission was to gain valuable insights into the pioneering initiatives driven by the UAE-funded institute, which is dedicated to revolutionizing the realm of paediatric surgery by enhancing precision, minimizing invasiveness, and prioritizing patient comfort.
During their visit, the UAE delegation engaged with children aged 5 to 17 who were undergoing medical treatment at the institute, experiencing firsthand the transformative impact of its cutting-edge methodologies. Additionally, the delegation conducted an illuminating tour of the Children’s National Hospital, engaging in insightful conversations with administrative, research, and medical personnel to delve into the remarkable accomplishments of the Sheikh Zayed Institute for Paediatric Surgical Innovation.
The distinguished delegation was welcomed by Michelle Riley-Brown, President and CEO of the Children’s National Hospital. Accompanying her were Michelle McGuire, Chief Strategy Officer; Anthony Sandler, Senior Vice President and Surgeon-in-Chief at the hospital; Dr. Kevin Cleary, Technical Director of the Bioengineering Initiative at the Sheikh Zayed Institute; Amanda Ranalli, Senior Director of International Advancement; Soraia Angiuoli, Executive Director of Global Services at the institute; and DeAnn Marshall, President of the Children’s National Hospital Foundation.
Abdulla Lootah, UAE’s Deputy Minister of Cabinet Affairs for Competitiveness and Knowledge Exchange, commended the institute’s groundbreaking scientific research and technological advancements, highlighting the significant contributions it has made to the field of children’s health.
Since its inception in 2009, the Sheikh Zayed Institute for Paediatric Surgical Innovation has achieved remarkable milestones in the domain of paediatric health. The institute boasts an impressive record of 40 patents for revolutionary pediatric medical innovations. Furthermore, it has undertaken and completed 1,500 active clinical research projects, extending exceptional care to over 246,000 patients. Notably, the institute has handled numerous unique and complex cases in 2021, further solidifying its position as a trailblazer in advancing pediatric healthcare.
The UAE delegation’s visit underscores the nation’s unwavering commitment to advancing medical innovation and fostering global collaboration for the betterment of children’s health and well-being.
